MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1373.98

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.12M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 198.16B
IQV IQVIA Holdings Inc

N/A

USD 42.64B
A Agilent Technologies Inc

N/A

USD 39.89B
LH Laboratory Corporation of Amer..

N/A

USD 18.12B
DGX Quest Diagnostics Incorporated

N/A

USD 16.66B
CRL Charles River Laboratories

N/A

USD 10.21B
QGEN Qiagen NV

N/A

USD 9.80B
VNRX Volitionrx Ltd

N/A

USD 0.07B
ENZ Enzo Biochem Inc

N/A

USD 0.06B
TMO Thermo Fisher Scientific Inc

N/A

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

N/A

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.69 % 0.39 %

N/A

CAD 0.28B
ZHU:CA BMO Equal Weight US Healt.. 1.69 % 0.00 %

N/A

CAD 0.01B
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 7.45B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 4.21M
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.27% 85% B 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.27% 85% B 65% D
Trailing 12 Months  
Capital Gain 34.67% 92% A 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.67% 92% A 74% C
Trailing 5 Years  
Capital Gain 100.81% 83% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.81% 83% B 84% B
Average Annual (5 Year Horizon)  
Capital Gain 16.46% 92% A 79% B-
Dividend Return 16.46% 92% A 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.68% 38% F 33% F
Risk Adjusted Return 53.66% 85% B 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.